Clinical Trial Update: Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion [Phase 3]

View source ↗

Summary

This is a Phase 3 trial evaluating postoperative adjuvant sintilimab in hepatocellular carcinoma with microvascular invasion. The study status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Tongji Hospital | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING